Literature DB >> 7838482

Comparative ototoxicity of cisplatin during acute and chronic treatment.

T Saito1, J M Aran.   

Abstract

Functional and morphological alterations were compared in guinea pig cochleae treated acutely (7.5 mg/kg x 2) and chronically (1.5 mg/kg x 10) with cisplatin. Drastic and rapid hearing impairments using compound action potential were observed only after the second injection during acute treatment. During chronic treatment, threshold changes were observed abruptly after 8 or 9 days of treatment. Morphological changes of outer hair cells were stronger in the acute treatment than the chronic one, and they appeared to concur with the functional data. Partial damage in the stria vascularis was observed only after acute treatment. From these results, it was suspected that acute and chronic ototoxic mechanisms differed according to the pharmacokinetics of cisplatin in the inner ear fluid and tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838482     DOI: 10.1159/000276683

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  8 in total

1.  The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs.

Authors:  T Saito; Z J Zhang; Y Manabe; T Ohtsubo; H Saito
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

2.  Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line.

Authors:  Henry C Ou; David W Raible; Edwin W Rubel
Journal:  Hear Res       Date:  2007-07-19       Impact factor: 3.208

3.  Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.

Authors:  Guiscardo Lorito; Stavros Hatzopoulos; Göran Laurell; Kathleen C M Campbell; Joseph Petruccelli; Pietro Giordano; Krzysztof Kochanek; Lech Sliwa; Alessandro Martini; Henryk Skarzynski
Journal:  Med Sci Monit       Date:  2011-08

4.  Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.

Authors:  C Bokemeyer; C C Berger; J T Hartmann; C Kollmannsberger; H J Schmoll; M A Kuczyk; L Kanz
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

5.  [Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy].

Authors:  Miguel Angelo Hyppolito; Antonio A de Oliveira; Ricardo Miranda Lessa; Maria Rossato
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-14

6.  The use of Maytenus ilicifolia to prevent cisplatin-induced ototoxicity.

Authors:  Cristiane Akemi Kasse; Oswaldo L M Cruz; Luis C N Iha; Henrique O Costa; Elaine C Lopes; Flávia Coelho
Journal:  Braz J Otorhinolaryngol       Date:  2008 Sep-Oct

7.  Audiological findings in patients treated with radiotherapy for head and neck tumors.

Authors:  Ana Helena Bannwart Dell'Aringa; Myrian de Lima Isaac; Gustavo Viani Arruda; Alfredo Rafael Dell'Aringa; Maria Carolina B N Esteves
Journal:  Braz J Otorhinolaryngol       Date:  2010 Jul-Aug

8.  Distortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cisplatin-induced ototoxicity in rats.

Authors:  Marcos Rabelo de Freitas; Viviane Carvalho da Silva; Gerly Anne de Castro Brito; José Valdir de Carvalho Junior; Raimundo Martins Gomes Junior; Ronaldo de Albuquerque Ribeiro
Journal:  Braz J Otorhinolaryngol       Date:  2009 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.